Skip to main content
Erschienen in: World Journal of Surgery 4/2007

01.04.2007

Risk Factors Contributing to a Poor Prognosis of Papillary Thyroid Carcinoma: Validity of UICC/AJCC TNM Classification and Stage Grouping

verfasst von: Yasuhiro Ito, MD, Akira Miyauchi, MD, Tomoo Jikuzono, MD, Takuya Higashiyama, MD, Yuuki Takamura, MD, Akihiro Miya, MD, Kaoru Kobayashi, MD, Fumio Matsuzuka, MD, Kiyoshi Ichihara, MD, Kanji Kuma, MD

Erschienen in: World Journal of Surgery | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

In 2002, the UICC/AJCC TNM classification for papillary thyroid carcinoma was revised. In this study, we examined the validity of this classification system by investigating the predictors of disease-free survival (DFS) and cause-specific survival (CSS) in patients.

Methods

We examined various clinicopathological features, including the component of the TNM classification, for 1,740 patients who underwent initial and curative surgery for papillary carcinoma between 1987 and 1995.

Results

Clinical and pathological T4a, clinical N1b in the TNM classification, and patient age were recognized as independent predictors of not only DFS, but also CSS of patients. Tumor size, male gender, and central node metastasis independently affected DFS only. There were 1,005 pathological N1b patients, but pathological N1b did not independently affect either DFS or CSS. Regarding the stage grouping, clinical stage IVA including clinical N1b more clearly affected DFS and CSS than pathological stage IVA including pathological N1b.

Conclusion

Clinical stage grouping was more useful than pathological stage grouping for predicting the prognosis of papillary carcinoma patients possibly because pathological stage overestimates the biological characteristics of many pathological N1b tumors.
Literatur
1.
Zurück zum Zitat Sobin LH, Wittekind C (eds). UICC: TNM classification of malignant tumors, 6th edition, New York, Wiley-Liss, 2002 Sobin LH, Wittekind C (eds). UICC: TNM classification of malignant tumors, 6th edition, New York, Wiley-Liss, 2002
2.
Zurück zum Zitat Sobin LH, Wittekind C (eds). UICC: TNM classification of malignant tumors, 5th edition, New York, Wiley, 1997 Sobin LH, Wittekind C (eds). UICC: TNM classification of malignant tumors, 5th edition, New York, Wiley, 1997
3.
Zurück zum Zitat Tscholl-Ducommun J, Hedinger CE. Papillary thyroid carcinomas. Morphology and prognosis. Virchow Arch A Pathol Anat Histol 1982;396:19–39CrossRef Tscholl-Ducommun J, Hedinger CE. Papillary thyroid carcinomas. Morphology and prognosis. Virchow Arch A Pathol Anat Histol 1982;396:19–39CrossRef
4.
Zurück zum Zitat Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805–828PubMedCrossRef Carcangiu ML, Zampi G, Pupi A, et al. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805–828PubMedCrossRef
5.
Zurück zum Zitat Schindler AM, van Melle G, Evequoz B, et al. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324–330PubMedCrossRef Schindler AM, van Melle G, Evequoz B, et al. Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324–330PubMedCrossRef
6.
Zurück zum Zitat Moreno-Egea A, Rodriguez-Gonzalez JM, Sola-Perez J, et al. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 1995;82:1092–1094PubMedCrossRef Moreno-Egea A, Rodriguez-Gonzalez JM, Sola-Perez J, et al. Multivariate analysis of histopathological features as prognostic factors in patients with papillary thyroid carcinoma. Br J Surg 1995;82:1092–1094PubMedCrossRef
7.
Zurück zum Zitat Bellantone R, Lombardi CP, Boscherini M, et al. Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 1998;68:237–241PubMedCrossRef Bellantone R, Lombardi CP, Boscherini M, et al. Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 1998;68:237–241PubMedCrossRef
8.
Zurück zum Zitat Li JD, Chao TC, Weng HF, et al. Prognostic variables of papillary thyroid carcinomas with local invasion. Endocr J 1999;46:91–98 Li JD, Chao TC, Weng HF, et al. Prognostic variables of papillary thyroid carcinomas with local invasion. Endocr J 1999;46:91–98
9.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45. Surg Today 2006;36:12–18PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45. Surg Today 2006;36:12–18PubMedCrossRef
10.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006;30:780–786PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006;30:780–786PubMedCrossRef
11.
Zurück zum Zitat Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1994;97:418–428PubMedCrossRef Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1994;97:418–428PubMedCrossRef
12.
Zurück zum Zitat Salvesen H, Njolstad PR, Akslen LA, et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 1992;158:583–589PubMed Salvesen H, Njolstad PR, Akslen LA, et al. Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur J Surg 1992;158:583–589PubMed
13.
Zurück zum Zitat Akslen LA, Myking AO, Salvesen H, et al. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29:44–51CrossRef Akslen LA, Myking AO, Salvesen H, et al. Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29:44–51CrossRef
14.
15.
Zurück zum Zitat Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567PubMedCrossRef Scheumann GF, Gimm O, Wegener G, et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559–567PubMedCrossRef
16.
Zurück zum Zitat Noguchi M, Kumaki T, Taniya T, et al. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases. Int Surg 1990;75:220–224PubMed Noguchi M, Kumaki T, Taniya T, et al. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases. Int Surg 1990;75:220–224PubMed
17.
Zurück zum Zitat Bellantone R, Lombardi CP, Boscherini M, et al. Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 1998;68:237–241PubMedCrossRef Bellantone R, Lombardi CP, Boscherini M, et al. Prognostic factors in differentiated thyroid carcinoma: a multivariate analysis of 234 consecutive patients. J Surg Oncol 1998;68:237–241PubMedCrossRef
18.
Zurück zum Zitat Bottger T, Klupp J, Gabbert HE, et al. Prognostically relevant factors in papillary thyroid cancer. Med Klin 1991;86:76–82 Bottger T, Klupp J, Gabbert HE, et al. Prognostically relevant factors in papillary thyroid cancer. Med Klin 1991;86:76–82
19.
Zurück zum Zitat Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996;3:534–538PubMedCrossRef Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996;3:534–538PubMedCrossRef
20.
Zurück zum Zitat Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000;166:29–33PubMedCrossRef Steinmuller T, Klupp J, Rayes N, et al. Prognostic factors in patients with differentiated thyroid carcinoma. Eur J Surg 2000;166:29–33PubMedCrossRef
21.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 2005;29:917–920PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 2005;29:917–920PubMedCrossRef
22.
Zurück zum Zitat Antonelli A, Miccoli P, Ferdeghini M. Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 1995;5:25–29PubMedCrossRef Antonelli A, Miccoli P, Ferdeghini M. Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 1995;5:25–29PubMedCrossRef
23.
Zurück zum Zitat Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821–1828.PubMedCrossRef Ito Y, Jikuzono T, Higashiyama T, et al. Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 2006;30:1821–1828.PubMedCrossRef
24.
Zurück zum Zitat Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198PubMedCrossRef Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 2000;135:1194–1198PubMedCrossRef
25.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 2004;28:498–501PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. Preoperative ultrasonographic examination for lymph node metastasis is useful when designing lymph node dissection for papillary microcarcinoma. World J Surg 2004;28:498–501PubMedCrossRef
26.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: How should it be treated? World J Surg 2004;28:1115–1121PubMedCrossRef Ito Y, Tomoda C, Uruno T, et al. Papillary microcarcinoma of the thyroid: How should it be treated? World J Surg 2004;28:1115–1121PubMedCrossRef
Metadaten
Titel
Risk Factors Contributing to a Poor Prognosis of Papillary Thyroid Carcinoma: Validity of UICC/AJCC TNM Classification and Stage Grouping
verfasst von
Yasuhiro Ito, MD
Akira Miyauchi, MD
Tomoo Jikuzono, MD
Takuya Higashiyama, MD
Yuuki Takamura, MD
Akihiro Miya, MD
Kaoru Kobayashi, MD
Fumio Matsuzuka, MD
Kiyoshi Ichihara, MD
Kanji Kuma, MD
Publikationsdatum
01.04.2007
Erschienen in
World Journal of Surgery / Ausgabe 4/2007
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-006-0455-0

Weitere Artikel der Ausgabe 4/2007

World Journal of Surgery 4/2007 Zur Ausgabe

OriginalPaper

Reply

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.